Tianjin Lisheng Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of March 2026: 17.92%

Tianjin Lisheng Pharmaceutical Co Ltd asset resilience ratio. Tianjin Lisheng Pharmaceutical Co Ltd (002393) has an Asset Resilience Ratio of 17.92% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002393 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥991.31 Million

≈ $145.06 Million USD Cash + Short-term Investments

Total Assets

CN¥5.53 Billion

≈ $809.66 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Tianjin Lisheng Pharmaceutical Co Ltd (2022–2025)

Asset resilience ratio of Tianjin Lisheng Pharmaceutical Co Ltd from 2022 to 2025. This chart shows how Tianjin Lisheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Tianjin Lisheng Pharmaceutical Co Ltd (002393) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Lisheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 002393 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥991.31 Million	17.92%
Total Liquid Assets	CN¥991.31 Million	17.92%

Asset Resilience Insights

Good Liquidity Position: Tianjin Lisheng Pharmaceutical Co Ltd maintains a healthy 17.92% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Tianjin Lisheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tianjin Lisheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Tianjin Lisheng Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2022–2025)

Tianjin Lisheng Pharmaceutical Co Ltd asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for Tianjin Lisheng Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	18.27%	CN¥1.02 Billion ≈ $149.30 Million	CN¥5.58 Billion ≈ $817.17 Million	+8.36pp
2024-12-31	9.91%	CN¥573.36 Million ≈ $83.90 Million	CN¥5.79 Billion ≈ $846.60 Million	+5.91pp
2023-12-31	4.00%	CN¥231.26 Million ≈ $33.84 Million	CN¥5.78 Billion ≈ $845.88 Million	+0.21pp
2022-12-31	3.79%	CN¥200.32 Million ≈ $29.31 Million	CN¥5.29 Billion ≈ $774.25 Million	--

pp = percentage points

About Tianjin Lisheng Pharmaceutical Co Ltd

SHE:002393 China Drug Manufacturers - Specialty & Generic

Market Cap

$579.25 Million

CN¥3.96 Billion CNY

Market Cap Rank

#11118 Global

#3021 in China

Share Price

CN¥12.84

Change (1 day)

+2.97%

52-Week Range

CN¥12.47 - CN¥24.25

All Time High

CN¥46.19